Published online Mar 27, 2024. doi: 10.4240/wjgs.v16.i3.790
Peer-review started: December 22, 2023
First decision: January 9, 2024
Revised: January 21, 2024
Accepted: February 29, 2024
Article in press: February 29, 2024
Published online: March 27, 2024
Processing time: 90 Days and 21.6 Hours
Upper gastrointestinal bleeding (UGIB) is divided into nonvariceal UGIB (NVUGIB) and variceal UGIB (VUGIB), with rising NVUGIB cases due to an aging population and more non-steroidal anti-inflammatory drugs use, and VUGIB typically resulting from liver cirrhosis with substantial mortality. Despite medical and endoscopic progress, UGIB main
UGIB prognostic scoring systems are inconsistently applied in clinical practice, with limited impact on decision-making due to variances in primary outcomes and lack of validation. The absence of trial-based evidence for these scores con
The goal of this study is to identify key factors that influence poor UGIB outcomes (e.g., the demand for emergency sur
A retrospective study used UGIB patient data from East Hospital as a training cohort and from Changzheng Hospital as a validation cohort to construct and test a new scoring model based on major predictors of UGIB outcomes, including en
Univariate analysis determined factors related to negative outcomes in UGIB, leading to the creation of the MH-STRALP scoring system, which incorporates seven prognostically significant factors plus the risk of rebleeding. The MH-STRALP system showed better prognostic accuracy compared to other established scoring systems (GBS, Rockall, ABC, AIMS65, and PNED), with areas under ROC curves (AUROC) of 0.899 and 0.826 in the training and validation cohorts, whilst the pre-MH-STRALP score also showed better predictive value (AUROCs of 0.868 and 0.767 in the training and validation cohorts, respectively).These two scoring systems are helpful in prognosticating Chinese UGIB patients, providing personalized appropriate treatment and management, and facilitating early clinical decision-making.
With this study, we constructed new scoring systems, MH-STRALP and pre-MH-STRALP, to predict the prognosis of patients with UGIB, with compound endpoint events of undergoing emergency surgery or vascular intervention, being transferred to the ICU, or dying during hospitalization; we formulated a nomogram to present the scoring system.
Since this is a retrospective study and we did not make prognostic predictions for patients with UGIB who did not un
